Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract canc

This topic has 3 replies, 1 voice, and was last updated 4 years, 3 months ago by gavin.

Viewing 4 posts - 1 through 4 (of 4 total)

Author

Posts
August 21, 2020 at 9:50 pm #100373

gavin
Moderator

Targeted therapy combination effective for patients with advanced cholangiocarcinoma and BRAF mutations

https://www.sciencecodex.com/targeted-therapy-combination-effective-patients-advanced-cholangiocarcinoma-and-braf-mutations

August 18, 2020 at 10:11 pm #100364

gavin
Moderator

Dabrafenib Plus Trametinib for Patients With BRAF V600E–Mutated Cholangiocarcinoma

https://ascopost.com/news/august-2020/dabrafenibtrametinib-for-patients-with-braf-v600e-mutated-cholangiocarcinoma/?email=0b78bf89ac8ef35ad4793e2385fe1c4fb5e909d4bb0ada7f211f6774dee92c4f&utm_medium=email&utm_source=TAPEN-Automated-US-Template&bc_md5=b50ee48c95ff9f6ae4ae9cd014d5ca9c#.XzxRyjW9rFc.twitter

August 18, 2020 at 1:53 pm #100363

gavin
Moderator

Targeted therapy combination effective for patients with advanced cholangiocarcinoma and BRAF mutations

https://www.sciencedaily.com/releases/2020/08/200817191745.htm

August 18, 2020 at 8:40 am #100361

gavin
Moderator

Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial

https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(20)30321-1/fulltext#.XzsGA0Dd3-Q.twitter

Thanks to The Lancet for this piece.

Gavin
Author

Posts

Viewing 4 posts - 1 through 4 (of 4 total)

The forum ‘Chemotherapy & More’ is closed to new topics and replies.

©2022 - All Rights Reserved, Cholangiocarcinoma Foundation